Finanzen von InflaRx NV (IFRX)IFRXInflaRx NV

Evaluating the bottom line, InflaRx NV maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -30.95%, provide a clear picture of how effectively IFRX converts its operational activities into shareholder value.

In the context of the broader market, IFRX competes directly with industry leaders such as OGCP and FATE. With a market capitalization of $218.11M, it holds a significant position in the sector. When comparing efficiency, IFRX's gross margin of N/A stands against OGCP's N/A and FATE's 100.00%. Such benchmarking helps identify whether InflaRx NV is trading at a premium or discount relative to its financial performance.

InflaRx has faced challenges with profitability, evidenced by a negative net income of -14,416,271 EUR in Q2 2025 and a gross margin of -5,985.37% in the same period. However, it has shown improvement with a gross profit of 23,497 EUR in Q3 2025, indicating potential recovery.